path2845_suppinfofs1.pdf14559KSupporting Information: Figure S1. Antigen profile comparison between AP+ and AP− cells.
path2845_suppinfofs2.pdf14560KSupporting Information: Figure S2. Teratoma formation by MAB-iPSCs.
path2845_suppinfofs3.pdf14560KSupporting Information: Figure S3. f-iPSCs teratomas and myogenic potential of MAB-iPSCs.
path2845_suppinfofs4.pdf14560KSupporting Information: Figure S4. Transposon-based GFP+ MAB-iPSCs creation.
path2845_suppinfofs5.pdf14559KSupporting Information: Figure S5. qRT–PCR analyses on transfected MAB-iPSCs.
path2845_suppinfofs6.pdf14560KSupporting Information: Figure S6. Myogenic differentiation potential of f-iPSCs and MAB-iPSCs.
path2845_suppinfofs7.pdf14560KSupporting Information: Figure S7. Schematic table and representation of methylation comparison between MAB-iPSCs and f-iPSCs.
path2845_suppinfofs8.pdf14560KSupporting Information: Figure S8. Nanog/Myo5a expression in MAB-iPSCs and f-iPSCs.
path2845_suppinfofs9.pdf14559KSupporting Information: Figure S9. αsg protein level quantifications.
path2845_suppinfofs10.pdf14559KSupporting Information: Figure S10. GFP expression in filter organs of injected mice.
path2845_suppinfosm.doc48KSupporting Information: Supplementary methods
path2845_suppinfo.doc33KSupporting Information: Legends to Figure S1 to S10

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.